BCM
ACCD

Bayesian Capital Management’s Accolade Inc ACCD Stock Holding History

Bayesian Capital Management’s Portfolio ACCD Stock Details ACCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,900
Closed -$37.3K – 1033
2024
Q4 		$37.3K Sell
10,900
-33,800
-76% -$120K ﹤0.01% 639
2024
Q3 		$172K Buy
44,700
+31,200
+231% +$122K 0.02% 577
2024
Q2 		$48.3K Buy
+13,500
New +$102K 0.01% 671

Other funds holding ACCD

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bayesian Capital Management's ACCD Position: Q1 2025 in Review

Bayesian Capital Management sold out of Accolade Inc (ACCD) in Q1 2025, closing a stake of 10,900 shares — an estimated $37.3K sold.

Bayesian Capital Management first reported a position in ACCD in Q2 2024 and held it in 3 quarters. The position peaked at $172K in Q3 2024. 157 funds tracked by Wall St. Rank hold ACCD as of Q1 2025.

  • Bayesian Capital Management reported no remaining Accolade Inc position as of Q1 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 10,900 Accolade Inc shares in Q1 2025, an estimated $37.3K.
  • Bayesian Capital Management first reported a position in Accolade Inc in Q2 2024 and held it in 3 quarters.
  • Bayesian Capital Management's Accolade Inc position peaked at $172K in Q3 2024.
  • 157 funds tracked by Wall St. Rank held Accolade Inc as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.